English Spanish Chinese Russian French Japanese Portuguese Hindi Telugu Tamil

Archivos de Medicina

  • ISSN: 1698-9465
  • H-Index der Zeitschrift: 26
  • Zitierbewertung der Zeitschrift: 9.83
  • Journal-Impact-Faktor: 7.03
Indiziert in
  • Genamics JournalSeek
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • CiteFactor
  • Scimago
  • Elektronische Zeitschriftenbibliothek
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • OCLC – WorldCat
  • Proquest-Vorladungen
  • Kommission für Universitätsstipendien
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Google Scholar
  • SHERPA ROMEO
  • Geheime Suchmaschinenlabore
Mehr sehen
Teile diese Seite

Abstrakt

Infección por SARS-CoV-2 en Dos Pacientes en Tratamiento con Adalimumab

Lavieri AJ, Greco CF and Raco SC

With the onset of the SARS-CoV-2 pandemic, there is uncertainty about whether biological agents may place patients at increased risk of infection or a more severe disease course, either from COVID-19 or its underlying pathology. This commentary offers patient advice recommendations based on the current available evidence. Although there are currently no specific data on infected patients being treated with biologics, we present two cases, which provide information on this situation. We conclude that biological agents would not have a negative effect on this population, in the face of possible viral infection.